376 related articles for article (PubMed ID: 7680056)
1. Basophil mediator release in atopic dermatitis.
Bull HA; Courtney PF; Bunker CB; Rustin MH; Pearce FL; Dowd PM
J Invest Dermatol; 1993 Mar; 100(3):305-9. PubMed ID: 7680056
[TBL] [Abstract][Full Text] [Related]
2. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma.
Bischoff SC; Zwahlen R; Stucki M; Müllner G; de Weck AL; Stadler BM; Dahinden CA
Int Arch Allergy Immunol; 1996 Jul; 110(3):261-71. PubMed ID: 8688673
[TBL] [Abstract][Full Text] [Related]
3. Patients with severe atopic dermatitis have activated circulating basophils.
James JM; Kagey-Sobotka A; Sampson HA
J Allergy Clin Immunol; 1993 Jun; 91(6):1155-62. PubMed ID: 7685363
[TBL] [Abstract][Full Text] [Related]
4. Cord blood basophil releasability: evaluation of histamine release and leukotriene C4 generation.
Miadonna A; Leggieri E; Tedeschi A; Lorini M; Motta G; Lucci G; Froldi M; Marini A; Zanussi C
Int Arch Allergy Appl Immunol; 1988; 86(1):42-7. PubMed ID: 2453473
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human basophil leukotriene release by antiinflammatory steroids.
Schleimer RP; Davidson DA; Peters SP; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):241-3. PubMed ID: 3874167
[TBL] [Abstract][Full Text] [Related]
6. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjects.
van der Donk EM; Blok W; Kok PT; Bruijnzeel PL
Prostaglandins Leukot Essent Fatty Acids; 1991 Sep; 44(1):11-7. PubMed ID: 1719566
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
[TBL] [Abstract][Full Text] [Related]
9. IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells.
Poto R; Quinti I; Marone G; Taglialatela M; de Paulis A; Casolaro V; Varricchi G
Front Immunol; 2022; 13():880412. PubMed ID: 35711458
[TBL] [Abstract][Full Text] [Related]
10. [An attempt to block histamine release from basophils granulocytes with antibodies obtained as a result of long-term immunization].
Szymaniak L
Ann Acad Med Stetin; 1998; 44():45-64. PubMed ID: 9857531
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of mediator release from human basophils induced by platelet-activating factor.
Columbo M; Casolaro V; Warner JA; MacGlashan DW; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1990 Dec; 145(11):3855-61. PubMed ID: 1700998
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
[TBL] [Abstract][Full Text] [Related]
13. Regulation of histamine release from human basophil leucocytes: role of H1, H2 and H3 receptors.
Tedeschi A; Lorini M; Arquati M; Miadonna A
Allergy; 1991 Nov; 46(8):626-31. PubMed ID: 1724117
[TBL] [Abstract][Full Text] [Related]
14. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.
Kurimoto Y; De Weck AL; Dahinden CA
Eur J Immunol; 1991 Feb; 21(2):361-8. PubMed ID: 1705512
[TBL] [Abstract][Full Text] [Related]
15. Altered releasability of vasoactive mediator secreting cells in atopic eczema.
Ring J; Dorsch W
Acta Derm Venereol Suppl (Stockh); 1985; 114():9-23. PubMed ID: 2408433
[TBL] [Abstract][Full Text] [Related]
16.
Kowal K; Bielecki P; DuBuske IV; DuBuske LM
Allergy Asthma Proc; 2017 May; 38(3):204-215. PubMed ID: 28441991
[TBL] [Abstract][Full Text] [Related]
17. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells.
Marone G; Casolaro V; Paganelli R; Quinti I
J Invest Dermatol; 1989 Aug; 93(2):246-52. PubMed ID: 2787823
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 3-dependent mediator release in basophils triggered by C5a.
Kurimoto Y; de Weck AL; Dahinden CA
J Exp Med; 1989 Aug; 170(2):467-79. PubMed ID: 2474054
[TBL] [Abstract][Full Text] [Related]
19. Study of IgE-dependent basophil releasability in allergic patients.
Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
[TBL] [Abstract][Full Text] [Related]
20. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables.
MacGlashan DW
J Allergy Clin Immunol; 1993 Feb; 91(2):605-15. PubMed ID: 7679683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
